• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬乳腺肿瘤中的乳腺癌跨物种致癌特征。

Cross-species oncogenic signatures of breast cancer in canine mammary tumors.

机构信息

Department of Medical Informatics and Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea.

Department of Biomedical Systems Informatics and Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, 03722, South Korea.

出版信息

Nat Commun. 2020 Jul 17;11(1):3616. doi: 10.1038/s41467-020-17458-0.

DOI:10.1038/s41467-020-17458-0
PMID:32680987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7367841/
Abstract

Genomic and precision medicine research has afforded notable advances in human cancer treatment, yet applicability to other species remains uncertain. Through whole-exome and transcriptome analyses of 191 spontaneous canine mammary tumors (CMTs) that exhibit the archetypal features of human breast cancers, we found a striking resemblance of genomic characteristics including frequent PIK3CA mutations (43.1%), aberrations of the PI3K-Akt pathway (61.7%), and key genes involved in cancer initiation and progression. We also identified three gene expression-based CMT subtypes, one of which segregated with basal-like human breast cancer subtypes with activated epithelial-to-mesenchymal transition, low claudin expression, and unfavorable disease prognosis. A relative lack of ERBB2 amplification and Her2-enrichment subtype in CMT denoted species-specific molecular mechanisms. Taken together, our results elucidate cross-species oncogenic signatures for a better understanding of universal and context-dependent mechanisms in breast cancer development and provide a basis for precision diagnostics and therapeutics for domestic dogs.

摘要

基因组学和精准医学研究为人类癌症治疗带来了显著进展,但在其他物种中的适用性仍不确定。通过对 191 例具有人类乳腺癌典型特征的自发性犬乳腺肿瘤(CMT)进行全外显子组和转录组分析,我们发现了包括 PIK3CA 突变(43.1%)在内的基因组特征惊人相似、PI3K-Akt 通路异常(61.7%)以及涉及癌症发生和进展的关键基因。我们还鉴定了三种基于基因表达的 CMT 亚型,其中一种与基底样人乳腺癌亚型分离,具有激活的上皮-间充质转化、低 Claudin 表达和不良的疾病预后。CMT 中相对缺乏 ERBB2 扩增和 Her2 富集亚型表明存在物种特异性的分子机制。综上所述,我们的研究结果阐明了跨物种致癌特征,有助于更好地理解乳腺癌发生中的普遍和依赖于背景的机制,并为犬类的精准诊断和治疗提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/12181ba9978a/41467_2020_17458_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/85bf9393ec55/41467_2020_17458_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/daa30321311a/41467_2020_17458_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/ddd805773308/41467_2020_17458_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/12181ba9978a/41467_2020_17458_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/85bf9393ec55/41467_2020_17458_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/daa30321311a/41467_2020_17458_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/ddd805773308/41467_2020_17458_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590d/7367841/12181ba9978a/41467_2020_17458_Fig4_HTML.jpg

相似文献

1
Cross-species oncogenic signatures of breast cancer in canine mammary tumors.犬乳腺肿瘤中的乳腺癌跨物种致癌特征。
Nat Commun. 2020 Jul 17;11(1):3616. doi: 10.1038/s41467-020-17458-0.
2
Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors.犬乳腺肿瘤与人类乳腺肿瘤分子亚型特征的比较分析。
J Mammary Gland Biol Neoplasia. 2022 Jun;27(2):171-183. doi: 10.1007/s10911-022-09523-9. Epub 2022 Aug 6.
3
Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.Claudin-low 样小鼠乳腺肿瘤表现出与基因组驱动因素解耦的独特转录组模式。
Breast Cancer Res. 2019 Jul 31;21(1):85. doi: 10.1186/s13058-019-1170-8.
4
Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.人类基底样乳腺癌表现为犬乳腺肿瘤的两种亚型之一。
Breast Cancer Res. 2023 Oct 3;25(1):114. doi: 10.1186/s13058-023-01705-5.
5
Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?通过基于抗体、转录组学和质谱分析研究犬乳腺肿瘤中HER2的表达:狗是否是人类乳腺癌的合适动物模型?
Tumour Biol. 2015 Nov;36(11):9083-91. doi: 10.1007/s13277-015-3661-2. Epub 2015 Jun 19.
6
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.小鼠乳腺上皮中极光激酶 -A 的过表达会诱发具有与人类乳腺癌共有的基因改变的乳腺腺癌。
Carcinogenesis. 2016 Dec;37(12):1180-1189. doi: 10.1093/carcin/bgw097. Epub 2016 Sep 13.
7
Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.恶性犬乳腺上皮细胞脱落含有差异表达 microRNA 的外泌体,这些 microRNA 调节致癌网络。
BMC Cancer. 2018 Aug 20;18(1):832. doi: 10.1186/s12885-018-4750-6.
8
PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia.PIK3CA 在犬乳腺肿瘤中经常发生突变,与人类乳腺肿瘤相似。
Sci Rep. 2023 Jan 12;13(1):632. doi: 10.1038/s41598-023-27664-7.
9
Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.通过单细胞 RNA 测序解析 BRCA1 缺陷型乳腺肿瘤的异质性和肿瘤发生机制。
Theranostics. 2021 Oct 25;11(20):9967-9987. doi: 10.7150/thno.63995. eCollection 2021.
10
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.比较肿瘤基因组学鉴定出富含功能性肿瘤起始细胞的乳腺肿瘤。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2778-83. doi: 10.1073/pnas.1018862108. Epub 2011 Jun 1.

引用本文的文献

1
β-Hydroxybutyrate promotes chemoresistance and proliferation in breast cancer cells.β-羟基丁酸促进乳腺癌细胞的化学抗性和增殖。
Biochem Biophys Rep. 2025 Aug 28;44:102217. doi: 10.1016/j.bbrep.2025.102217. eCollection 2025 Dec.
2
Expanding the Spectrum of Canine Diffuse Large B-Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis.通过全基因组测序分析扩展犬弥漫性大B细胞淋巴瘤基因畸变谱
Vet Comp Oncol. 2025 Sep;23(3):346-357. doi: 10.1111/vco.13059. Epub 2025 May 4.
3
Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer.

本文引用的文献

1
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.多模态基因组特征预测非小细胞肺癌免疫检查点阻断的疗效。
Nat Cancer. 2020 Jan;1(1):99-111. doi: 10.1038/s43018-019-0008-8. Epub 2020 Jan 13.
2
Whole-exome and whole-transcriptome sequencing of canine mammary gland tumors.犬乳腺肿瘤的全外显子组和全转录组测序。
Sci Data. 2019 Aug 14;6(1):147. doi: 10.1038/s41597-019-0149-8.
3
A systematic review of the international prevalence of mutation in breast cancer.乳腺癌基因突变国际患病率的系统评价。
犬、猫和鼠类乳腺肿瘤作为乳腺癌转化研究的模型
Vet Sci. 2025 Feb 19;12(2):189. doi: 10.3390/vetsci12020189.
4
Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient.个体化的CRISPR/Cas9联合筛选确定CDK2是一例犬乳腺癌患者的可药物靶向弱点。
Vet Sci. 2025 Feb 18;12(2):183. doi: 10.3390/vetsci12020183.
5
Dysregulated Signaling Pathways in Canine Mammary Tumor and Human Triple Negative Breast Cancer: Advances and Potential Therapeutic Targets.犬乳腺肿瘤和人类三阴性乳腺癌中失调的信号通路:进展与潜在治疗靶点
Int J Mol Sci. 2024 Dec 27;26(1):145. doi: 10.3390/ijms26010145.
6
Differential somatic coding variant landscapes between laser microdissected luminal epithelial cells from canine mammary invasive ductal solid carcinoma and comedocarcinoma.犬乳腺浸润性导管实性癌和粉刺癌的激光显微切割管腔上皮细胞之间的体细胞编码变异景观差异
BMC Cancer. 2024 Dec 18;24(1):1524. doi: 10.1186/s12885-024-13239-w.
7
Detection of PIK3CA hotspot mutations in canine mammary tumors using droplet digital PCR: tissue validation and liquid biopsy feasibility.应用液滴数字 PCR 检测犬乳腺肿瘤中 PIK3CA 热点突变:组织验证和液体活检可行性。
Sci Rep. 2024 Oct 26;14(1):25587. doi: 10.1038/s41598-024-76820-0.
8
Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet Dogs.肿瘤局部注射白细胞介素-2 和白细胞介素-12 联合放射治疗安全增强宠物犬晚期恶性黑色素瘤的消退。
Clin Cancer Res. 2024 Sep 13;30(18):4029-4043. doi: 10.1158/1078-0432.CCR-24-0861.
9
Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target.建立携带有 PI3K/Akt 激活的犬乳腺肿瘤细胞系作为治疗靶点。
BMC Vet Res. 2024 May 29;20(1):233. doi: 10.1186/s12917-024-04085-w.
10
Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future.分子生物标志物在犬猫肿瘤学中的临床应用:现状与未来
Vet Sci. 2024 May 2;11(5):199. doi: 10.3390/vetsci11050199.
Clin Epidemiol. 2019 Jul 11;11:543-561. doi: 10.2147/CLEP.S206949. eCollection 2019.
4
Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.利用全外显子组测序鉴定犬癌细胞系中的潜在可成药靶点。
Mol Cancer Ther. 2019 Aug;18(8):1460-1471. doi: 10.1158/1535-7163.MCT-18-1346. Epub 2019 Jun 7.
5
Alpelisib for -Mutated, Hormone Receptor-Positive Advanced Breast Cancer.阿培利司治疗 - 突变型、激素受体阳性晚期乳腺癌。
N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904.
6
Current biomarkers of canine mammary tumors.犬乳腺肿瘤的当前生物标志物。
Acta Vet Scand. 2018 Oct 29;60(1):66. doi: 10.1186/s13028-018-0417-1.
7
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.COSMIC 癌症基因目录:描述所有人类癌症中的遗传功能障碍。
Nat Rev Cancer. 2018 Nov;18(11):696-705. doi: 10.1038/s41568-018-0060-1.
8
The evolutionary landscape of colorectal tumorigenesis.结直肠癌发生的进化景观。
Nat Ecol Evol. 2018 Oct;2(10):1661-1672. doi: 10.1038/s41559-018-0642-z. Epub 2018 Aug 31.
9
Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.原发性和配对转移性犬乳腺癌上皮-间质转化的特征
Vet Pathol. 2018 Sep;55(5):622-633. doi: 10.1177/0300985818776054. Epub 2018 May 22.
10
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.癌症基因组图谱中 DNA 损伤修复缺陷的基因组和分子特征。
Cell Rep. 2018 Apr 3;23(1):239-254.e6. doi: 10.1016/j.celrep.2018.03.076.